Buprenorphine Extended-Release Injection and Dextenza intraocular
Determining the interaction of Buprenorphine Extended-Release Injection and Dextenza intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Dextran 40
- Buprenorphine Extended-Release Injection-Dextran 70 6% in 5% Dextrose high molecular weight
- Buprenorphine Extended-Release Injection-Dextran 75
- Buprenorphine Extended-Release Injection-Dextran high molecular weight
- Buprenorphine Extended-Release Injection-Dextranomer and Hyaluronate Derivatives (Deflux)
- Buprenorphine Extended-Release Injection-Dextranomer and Hyaluronate Derivatives (Solesta)
- Dextenza intraocular-Buprenorphine implant
- Dextenza intraocular-Buprenorphine Injection
- Dextenza intraocular-Buprenorphine injection - Buprenex
- Dextenza intraocular-Buprenorphine injection - Sublocade
- Dextenza intraocular-Buprenorphine Intradermal
- Dextenza intraocular-Buprenorphine oral/buccal